InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006697 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-05 2024-03-01 WGS Feeley Kevin CFO M - OptEx $0.00 +718 23.8K +3% $0
D 2024-03-05 2024-03-04 WGS Feeley Kevin CFO S - Sale+OE $8.57 -301 23.5K -1% -$2,580
D 2024-03-05 2024-03-01 WGS Feeley Kevin CFO M - OptEx $0.00 -718 7,173 -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-03-01 M A 718 $0.00 23,753 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2024-03-04 S D 301 $8.57 23,452 D — —
3 Derivative Restricted Stock Unit 2024-03-01 M D 718 $0.00 7,173 D — · — to — 718 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.